Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington’s Disease
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by a trinucleotide expansion in the HD gene, resulting in an extended polyglutamine tract in the protein huntingtin. HD is traditionally viewed as a movement disorder, but cognitive and neuropsychiatric symptoms als...
Saved in:
Main Authors: | Cristine de Paula Nascimento-Castro, Ana Claudia Wink, Victor Silva da Fônseca, Claudia Daniele Bianco, Elisa C. Winkelmann-Duarte, Marcelo Farina, Ana Lúcia S. Rodrigues, Joana Gil-Mohapel, Andreza Fabro de Bem, Patricia S. Brocardo |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2018/4056383 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synaptic modulation of glutamate in striatum of the YAC128 mouse model of Huntington disease
by: Judy Cheng, et al.
Published: (2025-02-01) -
The Role of the Immune System in Huntington’s Disease
by: Gisa Ellrichmann, et al.
Published: (2013-01-01) -
Potentials of Curcumin as an Antidepressant
by: S.K. Kulkarni, et al.
Published: (2009-01-01) -
deutetrabenazine for the treatment of chorea associated with Huntington’s disease
by: Harshit Gupta, et al.
Published: (2022-06-01) -
The Role of Dopamine and Glutamate Modulation in Huntington Disease
by: Sumeer K. Mittal, et al.
Published: (2013-01-01)